Blood samples from patients with long COVID who are still suffering from fatigue and shortness of breath after a year show signs of autoimmune disease, according to a study published today (Thursday) in the European Respiratory Journal [1].
Autoimmune disease occurs when the immune system mistakenly attacks healthy parts of the body, instead of defending the body against disease. It causes conditions such as rheumatoid arthritis and lupus.
Researchers say this finding offers clues about the nature of long COVID that could ultimately lead to improvements in diagnosing and treating the condition.
The research was led by Dr Manali Mukherjee from McMaster University, Ontario, Canada and Professor Chris Carlsten at the University of British Columbia, Vancouver, Canada. Dr Mukherjee said: “Although long COVID is now recognised by bodies like the World Health Organization, we still know very little about why it develops or how we can help patients.
“I’m a respiratory researcher with a background in studying the immune system and when I experienced the symptoms of long COVID first-hand, I began to wonder about the role of the immune system in this condition.”
To find out more, Dr Mukherjee and her colleagues recruited 106 people who had been diagnosed with COVID-19 between August 2020 and September 2021 and were under the care of three hospitals in Canada (St. Joseph’s Healthcare Hamilton, Vancouver General Hospital and St. Paul’s Hospital, Vancouver). Researchers also included a group of 22 healthy volunteers and a group of 34 people who had experienced a non-COVID respiratory infection as a comparison.
On three occasions – three, six and 12 months after they recovered from the infection – patients were asked if they were suffering any shortness of breath, coughing or fatigue (typical symptoms of long COVID). Most patients were still taking part in the study after six months (98 out of 106) while only 57 came back after 12 months. Researchers say this may be due to patients recovering.
Participants also gave blood samples. Researchers tested the samples for particular antibodies. Antibodies are normally produced by the immune system to stick to potentially harmful bacteria or viruses, marking them out for attack by other parts of the immune system. In this case, the researchers looked for antibodies that target healthy cells and tissues in the body and that are known to contribute to autoimmune diseases.
Nearly 80% of the COVID-19 patients had two or more of these antibodies in their blood three months and six months after the infection. This fell to 41% after a year. Most of the healthy volunteers had no sign of these antibodies in their blood and in those who had experienced a non-COVID respiratory infection, levels of these antibodies were comparatively low.
Researchers also found that two specific ‘autoantibodies’ (called U1snRNP and SSb-La autoantibodies), along with other proteins (called cytokines) that cause inflammation, persisted in around 30% of COVID patients a year after infection. This tended to be among those patients who were also still suffering with fatigue and shortness of breath.
Dr Mukherjee explains: “For the majority the patients in our study, even if they had autoantibodies soon after their infection, this resolved after 12 months. However, in some patients, autoantibodies persist, and these patients are more likely to continue suffering with symptoms and to need medical help.
“These results point towards the need to test for signs of autoimmune disease in patients with symptoms of long COVID that last for a year or more.”
Professor Carlsten added: “Our data on autoantibodies in those months following COVID infection buttresses that of other groups and provides strong plausibility for the presentation of long COVID as a systemic disease.”
Dr Mukherjee and her colleagues will now study long COVID patients over a period of two years to see how their levels of autoantibodies change in the longer term.
Dr Eva Polverino from Vall d’Hebron University Hospital, Barcelona, Spain, is Head of the European Respiratory Society’s Respiratory Infections Assembly and was not involved in the research. She said: “Millions of people around the world are suffering with long COVID and that is having an enormous socioeconomic impact. However, there is a lack of evidence on why some people develop the condition and how we can help patients recover.
“We know that certain infections can, in some cases, trigger longer-term autoimmune diseases such as rheumatoid arthritis. This study adds to growing evidence that similar processes may be involved in long COVID. Further work in this area could increase our understanding of long COVID and how best to diagnose and treat the condition.”

News
Unlocking hidden soil microbes for new antibiotics
Most bacteria cannot be cultured in the lab-and that's been bad news for medicine. Many of our frontline antibiotics originated from microbes, yet as antibiotic resistance spreads and drug pipelines run dry, the soil [...]
By working together, cells can extend their senses beyond their direct environment
The story of the princess and the pea evokes an image of a highly sensitive young royal woman so refined, she can sense a pea under a stack of mattresses. When it comes to [...]
Overworked Brain Cells May Hold the Key to Parkinson’s
Scientists at Gladstone Institutes uncovered a surprising reason why dopamine-producing neurons, crucial for smooth body movements, die in Parkinson’s disease. In mice, when these neurons were kept overactive for weeks, they began to falter, [...]
Old tires find new life: Rubber particles strengthen superhydrophobic coatings against corrosion
Development of highly robust superhydrophobic anti-corrosion coating using recycled tire rubber particles. Superhydrophobic materials offer a strategy for developing marine anti-corrosion materials due to their low solid-liquid contact area and low surface energy. However, [...]
This implant could soon allow you to read minds
Mind reading: Long a science fiction fantasy, today an increasingly concrete scientific goal. Researchers at Stanford University have succeeded in decoding internal language in real time thanks to a brain implant and artificial intelligence. [...]
A New Weapon Against Cancer: Cold Plasma Destroys Hidden Tumor Cells
Cold plasma penetrates deep into tumors and attacks cancer cells. Short-lived molecules were identified as key drivers. Scientists at the Leibniz Institute for Plasma Science and Technology (INP), working with colleagues from Greifswald University Hospital and [...]
This Common Sleep Aid May Also Protect Your Brain From Alzheimer’s
Lemborexant and similar sleep medications show potential for treating tau-related disorders, including Alzheimer’s disease. New research from Washington University School of Medicine in St. Louis shows that a commonly used sleep medication can restore normal sleep patterns and [...]
Sugar-Coated Nanoparticles Boost Cancer Drug Efficacy
A team of researchers at the University of Mississippi has discovered that coating cancer treatment carrying nanoparticles in a sugar-like material increases their treatment efficacy. They reported their findings in Advanced Healthcare Materials. Over a tenth of breast [...]
Nanoparticle-Based Vaccine Shows Promise in Fighting Cancer
In a study published in OncoImmunology, researchers from the German Cancer Research Center and Heidelberg University have created a therapeutic vaccine that mobilizes the immune system to target cancer cells. The researchers demonstrated that virus peptides combined [...]
Quantitative imaging method reveals how cells rapidly sort and transport lipids
Lipids are difficult to detect with light microscopy. Using a new chemical labeling strategy, a Dresden-based team led by André Nadler at the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) and [...]
Ancient DNA reveals cause of world’s first recorded pandemic
Scientists have confirmed that the Justinian Plague, the world’s first recorded pandemic, was caused by Yersinia pestis, the same bacterium behind the Black Death. Dating back some 1,500 years and long described in historical texts but [...]
“AI Is Not Intelligent at All” – Expert Warns of Worldwide Threat to Human Dignity
Opaque AI systems risk undermining human rights and dignity. Global cooperation is needed to ensure protection. The rise of artificial intelligence (AI) has changed how people interact, but it also poses a global risk to human [...]
Nanomotors: Where Are They Now?
First introduced in 2004, nanomotors have steadily advanced from a scientific curiosity to a practical technology with wide-ranging applications. This article explores the key developments, recent innovations, and major uses of nanomotors today. A [...]
Study Finds 95% of Tested Beers Contain Toxic “Forever Chemicals”
Researchers found PFAS in 95% of tested beers, with the highest levels linked to contaminated local water sources. Per- and polyfluoroalkyl substances (PFAS), better known as forever chemicals, are gaining notoriety for their ability [...]
Long COVID Symptoms Are Closer To A Stroke Or Parkinson’s Disease Than Fatigue
When most people get sick with COVID-19 today, they think of it as a brief illness, similar to a cold. However, for a large number of people, the illness doesn't end there. The World [...]
The world’s first AI Hospital, developed in China is transforming healthcare
Artificial Intelligence and its developments have had a revolutionary impact on society, and healthcare is not an exception. China has made massive strides in AI integrated healthcare, and continues to do so as AI [...]